PIK3CB and breast cancer: The PTEN/PI3K/AKT signaling pathway is also the target of miR-301a-3p from esophageal squamous cancer cell-derived EVs (65) and miR-222 from Adriamycin-resistant MCF-7 breast cancer cell-derived EVs (66) to induce M2 polarization.